Journal of Medicinal Chemistry p. 1613 - 1618 (1993)
Update date:2022-08-03
Topics:
Ohshima
Sato
Obase
Miki
Ishii
Kawakage
Shirakura
Karasawa
Kubo
A new series of 6,11-dihydrodibenz[b,e]oxepin derivatives exerting both thromboxane synthase inhibitory (TXS-I) and thromboxane receptor antagonist (TXRA) activities is described. (-)-11-[(3-Pyridylmethyl)thio]-6,11- dihydrodibenz[b,e]oxepin-2-carboxylic
View MoreContact:0571-
Address:zhejing
Shanghai Haoyuan Chemexpress Co., Ltd.
website:https://www.chemexpress.com/
Contact:86-21-58950125
Address:No.3 Building, No.1999, Zhangheng Road, ZhangjiangHighTech Park, Shanghai, P.R.China,201203
Dongguan Albiya Energy Science and Technology Co.,Ltd
Contact:+86-769-22181286
Address:Huanan Industial Park, Dongguan,China
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Sanming Coffer Fine Chemical Industrial Co., Ltd
website:http://www.cofferxm.com/
Contact:+86-598-5853979
Address:Jin-sha Yuan Chuang-ye Park,Hi-Tech Development Zone,Sanming City P.R.China
Doi:10.1021/om00029a032
(1993)Doi:10.1039/jr9470000433
()Doi:10.1002/recl.19931120211
(1993)Doi:10.1039/J19700002922
()Doi:10.1021/ja00063a009
(1993)Doi:10.1039/c9cc08009k
(2020)
